Compound derived from hops reduces abundance of gut microbe associated with metabolic syndrome
Researchers have shown in a mouse model and lab cultures that a compound derived from hops reduces the abundance of a gut bacterium associated with metabolic syndrome. The findings, published today in the journal Microbiome, are important because an estimated 35 percent of the U.S. adult population suffers from the syndrome, a common and serious […]
Novel Turmeric Derivative Drug Shows Promise in Head and Neck Cancer
MONTREAL – An investigational drug derived from turmeric (Curcuma longa) appeared to have activity in patients being evaluated for head and neck cancer therapy, at least in an early phase trial. All nine oropharyngeal squamous cell carcinoma patients treated in the phase II trial had their disease under control after 4 to 6 weeks of […]
Quinine: Malaria Uses, Warnings, Side Effects, Dosage
What is quinine, and what is it used for? Quinine is a naturally occurring compound (alkaloid) derived from the bark of the cinchona tree. Quinine is used to treat malaria, a disease with high fevers, shaking chills, and flu-like illness. Malaria is caused by microscopic unicellular parasites belonging to the Plasmodium species, and malaria caused […]
Pinniped craniofacial musculature provides insight on its role in aquatic feeding
Pinnipeds — a group including seals, sea lions and walruses — are relatively recently derived marine mammals that evolved from terrestrial carnivorans and reentered the marine environment. Their recent adaptations to an amphibious lifestyle make their evolutionary anatomy of particular interest to Baylor University researcher Sarah Kienle, Ph.D., assistant professor of biology. “I’m fascinated by […]
Cell Therapy Safe and Effective in Women with Prior Urinary Incontinence Surgery
Autologous muscle derived cells for urinary sphincter repair (AMDC-USR) to treat stress urinary incontinence (SUI) was safe and durable, particularly for women who have undergone prior SUI surgery, a researcher reported. In a randomized phase III study, 36.9% of women receiving AMCD-USR achieved a strong response (≥75% reduction in stress incontinence episode frequency at 12 […]